App-Quantinova.ai

A multinomial approach to prediction of methotrexate treatment response and discontinuation due to adverse events in rheumatoid arthritis

Celina K Gehringer - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Assessing the health equity impacts of smartphone-based remote monitoring in people with rheumatoid arthritis: a stakeholder engagement workshop

Mariam Al-Attar - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Roxithromycin

The need for a funded, national HLH service: a scoping survey assessing the provision of specialist HLH services across the UK

Miriam F Cox - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Anakinra

GIRFT in action: Advanced Practice Physiotherapist and Advanced Practice Nurse expertise provides valuable triage and assessment clinics for non-urgent Rheumatology referrals

Carol McCrum - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Development and evaluation of a text-analytics algorithm for automated application of the BSR COVID-19 shielding criteria in rheumatology patients

Meghna Jani - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

hydrocortisone + gentamicin

Hydroxychloroquine retinopathy incidence in a UK specialist centre: a machine learning/natural language processing pilot study

Yasser Mushtaq - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Diabetic retinopathy

Hydroxychloroquine

Patient engagement in long-term PROMs collection: 48-month observation in real-world clinical practice

Iuliia Biliavska - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Preterm premature rupture of the membranes

N/A

Utilising a pharmacist-designed best value biologic and targeted synthetic shared decision-making tool to empower patients, support clinicians and save NHS resources

Nidhimol Mathews - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Giant Cell Arteritis Diagnosis: Metadiagnosis by robust Bayesian estimate of strength of belief

Louis Clearkin - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

N/A

Analysis of antibody response to SARS-CoV-2 vaccination and natural infection in a tertiary centre cohort of lupus nephritis patients

Katie Townsend - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Lupus nephritis

N/A

Immunosuppression doubles the risk of COVID-19 infection in a large vaccinated cohort of 898 patients with rheumatic diseases: implications for future practice

Natasha Cox - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

SJ8903

Pneumocystis Jirovecii Infection in autoimmune inflammatory rheumatic diseases in Oxford

Ayna Verdiyeva - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Cyclophosphamide

A review of intra-articular corticosteroid injection safety and clinical effectiveness during COVID-19

Gary J McCall - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Triamcinolone acetonide

A survey of COVID-19 infections in rheumatology patients in Shropshire, UK

Ali El Rashid - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

COVID vaccine made my joints hurt: effect of COVID vaccine on systemic rheumatic disease

Asif Munir - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

COVID shielding stories: co-produced research to understand the voice of people living with arthritis and auto-immune disease

Charlotte A Sharp - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory Arthritis

N/A

Incidence and Clinical Outcomes of New-onset Autoimmune Connective Tissue Diseases after COVID-19 Infection- A Systematic Literature Review

Koushan Kouranloo - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Lupus

N/A

Post COVID-19 Syndrome in patients with autoimmune rheumatic diseases: Results from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study

Latika Gupta - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients

Rhea Suribhatla - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Motivators, facilitators and barriers for patients and healthcare professionals towards exercise programmes in inflammatory rheumatic diseases: a qualitative literature review

Raj Amarnani - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Filters

45280 Abstracts